TipRanks
Go Ultimate55% OFF

Healthpeak Properties (DOC) AI Stock Analysis

MX:DOC

Healthpeak Properties

(BMV:DOC)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Balance SheetHealthpeak’s moderate leverage, substantial liquidity, and recent debt repayment provide financial flexibility through changing real-estate conditions. This supports ongoing investment, capital recycling, and selective acquisitions while reducing reliance on additional borrowing over the next several quarters.
Negative Factors
Lab OccupancyLife-science properties remain less fully occupied than the outpatient portfolio, limiting near-term NOI contribution from that segment. Uncertain absorption timing could prolong vacancy costs and delay the earnings benefit of leasing activity despite an improving pipeline.

Healthpeak Properties Business Overview & Revenue Model

Company Description

Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research...

Healthpeak Properties Earnings Call Summary

Earnings Call Date:Aug 03, 2026(Q2-2026)|Next Earnings Date:Feb 07, 2027
Earnings Call SentimentPositive

The call highlighted meaningful operational progress: strong balance sheet metrics (net debt/EBITDA 4.7x), sizable liquidity, large JV partnerships (Brookfield/Blackstone) that raise $1B+ in proceeds while preserving control, strong outpatient leasing (1.2M SF in Q2; occupancy to 90.7%), lab leasing momentum and occupancy improvement (78.5%, +140 bps YTD), and significant senior housing/Janus performance (45% revenue growth, 34% adjusted EBITDA growth). Challenges remain, notably lab occupancy still below peak, selective elevated CapEx needs for redevelopments, elevated borrowing costs limiting leverage options, cautious tenant timelines, and only a modest FFO guidance raise. Overall the positive operational momentum, strategic partnerships, and strong liquidity and balance sheet outweigh the remaining execution and market risks.

Positive Updates

Strong Balance Sheet and Liquidity
Net debt to adjusted EBITDA of 4.7x (below 5x), $4.1 billion of available liquidity, $900 million of debt repaid through Aug 4 (including $650 million of senior unsecured notes in July), and guidance that the company can maintain leverage below its 5.5x long-term target.

Negative Updates

Lab Occupancy Still Below Target
Lab total occupancy is 78.5%, improving but still materially below outpatient levels; management said same-store inflection timing is unclear and continued net absorption will be required to drive NOI inflection.

Company Guidance

On guidance, Healthpeak raised full‑year FFO as adjusted by $0.02 to $1.73–$1.77 per share, driven by a 75‑basis‑point increase in total same‑store NOI at the midpoint (including +200 bps each for lab and senior housing) and recognition of lower market interest amortization tied to a $400 million seller‑note repayment; the company reported Q2 FFO as adjusted of $0.46, ended the quarter with net debt/adjusted EBITDA of 4.7x (leverage below 5x vs. a 5.5x long‑term target), expects roughly $1.9 billion of gross capital‑recycling proceeds through year‑end, has completed $1.0 billion of acquisitions and buybacks to date, repaid $900 million of debt (including $650 million of senior notes in July), holds $4.1 billion of available liquidity, and cited ongoing optionality to deploy capital into preleased outpatient development, JV acquisitions, or opportunistic buybacks (having repurchased $100 million in April at a >10% FFO yield when the stock was under $17).

Healthpeak Properties Risk Analysis

Healthpeak Properties disclosed 58 risk factors in its most recent earnings report. Healthpeak Properties reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Healthpeak Properties Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

MX:DOC against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
OHIOHI80Outperform$14.24B16.2616.51%5.73%15.18%72.69%
Sector *65Neutral$2.17B12.193.79%4.94%3.15%1.96%
SBRASBRA65Neutral$5.04B74.772.34%6.08%18.43%-65.50%
HRHR60Neutral$6.26B-129.94-1.04%5.19%-6.28%77.63%
MPTMPT47Neutral$1.34B5.395.45%16.00%10.53%―
NHPNHP44Neutral$336.11M-8.02-6.25%0.99%-0.51%44.14%

* Real Estate Sector Average

Performance Comparison

-40%-20%0%20%40%OHISBRAMPTHRNHPDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:DOC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
OHIOmega Healthcare Investors46.986.7616.80%
SBRASabra Healthcare Reit19.742.9017.21%
MPTMedical Properties Trust, Inc.2.25-2.46-52.23%
HRHealthcare Realty Trust Incorporated18.491.7310.34%
NHPNational Healthcare Properties, Inc. Class A15.083.2026.90%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.